Oncology RWE in Action: Biomarkers, Outcomes & Effectiveness | Volume 3

Skip to content
Skip to footer

Oncology Data for Commercial & Brand ON.ClinicalDataView ON.Insights Alerts

Oncology Data for HEOR & Research ON.OutcomesView ON.JourneyView

Oncology Data for Clinical Development

Real-world Research

Ontada's research expertise covers the entire process, from proposal to publication, with clinical support from practicing oncologists acting as principal investigators, research support from Ontada's Medical Office, and researchers with over 400+ real-world publication contributions

Ontada Learn Digital Education Meetings & Events Practice-based Education Strategy & Effectiveness

Cancer care usually happens outside of experimental settings, but patient genomic data isn't commonly used to make decisions. Genospace uses patient data from next-generation sequencing to create market reports. Real-world evidence is vital to understanding genomics in cancer progression and therapeutic interaction.

Join Ontada at oncology conferences across the country to see how our data, research, and provider education solutions can help your company advance cancer care

Keep yourself informed about the most recent news and announcements from Ontada. Discover the latest developments in oncology research and healthcare solutions.

Our thought leaders share expertise, research, and insights in top oncology publications. Join us to stay updated on cancer care advancements.

Explore curated oncology resources that support strategy development in real-world data, provider engagement and real-world research.

Ontada, whose name is a combination of “oncology” and “data,” was formed with the vision that transforming cancer care requires speed. Our commitment is to provide the most current evidence in oncology treatment so insights can be generated faster.

Leadership Team

Ontada is on a mission to transform cancer care and improve the lives of patients, setting new standards in the integration of research and clinical practice to generate real-world data, insights and evidence. Meet our team leading the way.

We need smart, ambitious and empathetic people to help us build the future of cancer treatment. Join us on the frontline of oncology innovation.

Oncology real world data and research: Generating evidence with 12 research studies vol 3

As real-world evidence (RWE) becomes more integrated into healthcare decision-making, the number of use cases it supports is growing. By offering value throughout the drug development cycle, RWE can help biopharma companies shorten development time, reduce the cost of clinical trials, inform clinical practice and clarify the value of new therapies.

Our third volume of our publication booklet highlights the power of real-world data (RWD) in generating evidence across a range of therapeutic areas.

What’s Inside:

Contemporary biomarker testing rates in early and advanced non-small cell lung cancer (NSCLC)
Real-world outcomes in patients receiving nivolumab for melanoma
Real-world comparative effectiveness of palbociclib in metastatic breast cancer
And more

Download Vol. 3 to explore contemporary biomarker testing, treatment outcomes and comparative effectiveness research.

top